
David Planchard
Apr 4, 2025, 07:02
David Planchard: BRAF in NSCLC – From molecular mechanisms to clinical practice
David Planchard, Thoracic Pathologist Committee at Gustave Roussy, shared a post on LinkedIn:
“Superb progress for our BRAF lung cancer patients, but there’s still a long way to go…requiring collaborative work like that underway with the BOLERO consortium, Sandra Ortiz Cua, Julien Mazieres, so don’t hesitate to join us!”
“BRAF in NSCLC – From molecular mechanisms to clinical practice.”
Authors: Claudia Parisi, David Planchard
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 4, 2025, 06:52
Apr 4, 2025, 06:38
Apr 4, 2025, 05:24